GLP-1

Glucagon-like peptide-1 — an incretin hormone and target of several approved diabetes and obesity medicines.

GLP-1 receptor agonists mimic or amplify GLP-1 signaling to improve glucose-dependent insulin secretion, slow gastric emptying, and reduce appetite. Medications in this class are prescription-only in typical care pathways and require medical supervision.

Find my match